Stuart W. Peltz

2015

In 2015, Stuart W. Peltz earned a total compensation of $10.5M as Chief Executive Officer at PTC Therapeutics, a 110% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$310,000
Option Awards$9,600,480
Salary$600,000
Other$8,243
Total$10,518,723

Peltz received $9.6M in option awards, accounting for 91% of the total pay in 2015.

Peltz also received $310K in non-equity incentive plan, $600K in salary and $8.2K in other compensation.

Rankings

In 2015, Stuart W. Peltz's compensation ranked 460th out of 13,638 executives tracked by ExecPay. In other words, Peltz earned more than 96.6% of executives.

ClassificationRankingPercentile
All
460
out of 13,638
97th
Division
Manufacturing
152
out of 5,190
97th
Major group
Chemicals And Allied Products
62
out of 1,854
97th
Industry group
Drugs
49
out of 1,528
97th
Industry
Pharmaceutical Preparations
39
out of 1,182
97th
Source: SEC filing on April 27, 2017.

Peltz's colleagues

We found four more compensation records of executives who worked with Stuart W. Peltz at PTC Therapeutics in 2015.

2015

Shane Kovacs

PTC Therapeutics

Chief Financial Officer

2015

Mark Boulding

PTC Therapeutics

Chief Legal Officer

2015

Mark Rothera

PTC Therapeutics

Chief Commercial Officer

2015

Neil Almstead

PTC Therapeutics

Executive Vice President, Research, Pharmaceutical Operations & Technology

News

In-depth

You may also like